CMS Contradicts Lawmakers' Promise to Shield Cancer Patients
Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise https://t.co/ssiinnHHWH via @statnews
HHS Assures Experimental Ebola Treatment for High‑risk Americans
HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy https://t.co/69b364ZHlm via @statnews
New Pancreatic Cancer Drug Shows Survival Boost
People who don't follow cancer research often ask me why we haven't cured cancer. That perception masks a wonderful reality: We make amazing, stepwise progress every year, and the result is that many people live much longer today than they...
Peter Marks Drives Lilly’s Three‑vaccine Developer Acquisition
It looks like Peter Marks is making his mark. Eli Lilly to acquire three small vaccine developers https://t.co/vdkObEYWjj
FDA Turnover Delays Rare Disease Drug Development, Experts Warn
Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development https://t.co/H3z7G2kQyc via @statnews
AI Tool Guides Doctors to Treat Newborn’s Rare Disease
How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’ An AI tool, Biomedical Data Translator, helped doctors at Mayo Clinic find a treatment for Jorie Kraus https://t.co/3qs1WIDquU
Calm Leadership: Diamantas Poised to Benefit Biotech
‘No drama’ Diamantas should serve biotech well as acting FDA chief A nice column from @adamfeuerstein, who apparently ate his Wheaties today. https://t.co/zh5CU9Sv69 via @statnews
Gene Therapy Virus Implicated in Boy's Tumor, Study Finds
Scientists link boy’s tumor to gene therapy viruses, in rare finding https://t.co/d2jWn0zs9C via @statnews By @Jasonmmast
Makary Exits FDA; Diamantas Assumes Top Food Role
Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in https://t.co/JacvIrgWAe via @statnews
Beware Payer Panic; GLP‑1 Drugs Defy Bankruptcy Predictions
This is a reminder: when payers warn a new class of drugs will bankrupt a system, be cautious. We saw this with PCSK9 cholesterol meds, and then with Alzheimer's drugs. Unless of course that class of drugs begins with G and...
Rare Disease Community Gains New Treatment Hope After Five Years
Five years after disaster, a rare disease community gets new chance at treatment Yet another heart-rending story from @Jasonmmast. https://t.co/9vgOKpInL3
Vinay Prasad’s CV Misstates President’s Cancer Panel Membership
The Cancer Letter reports that Vinay Prasad’s CV inaccurately claimed past membership on the President’s Cancer Panel. Prasad did nor respond to repeated requests for comment, the publication said. https://t.co/ZbYKOKQ95c
NEJM Publishes Moderna Flu Data After FDA Refusal
A Friday footnote: The New England Journal of Medicine has published the Moderna influenza vaccine data -- the same that led the FDA's CBER division to refuse to review the vaccine under Vinay Prasad. (That decision, called a refuse-to-file or...
Dystopian AI-Generated ASCO Posters Mock ALS Treatment
Weird AI-generated ASCO posters? Drinking gold to treat ALS? @adamfeuerstein sends a dispatch from our dystopian future. TLDR: it sounds awful but it is fun to read about. https://t.co/SaniqEGPPn
Angelini Pharma Acquires Catalyst, Boosts US Rare‑Disease Portfolio
Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B The deal will expand the Italian pharma company’s work in the U.S. https://t.co/BwO6uGKvrT